Autotransfusion Devices Market Size & Share, by Application (Orthopedic, Cardiovascular, Neurological, Gynecological, Obstetrics, Other Surgeries); Product Type (Autotransfusion Systems, Accessories); End-user (Hospitals, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4459
  • Published Date: Feb 24, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2033

Autotransfusion Devices Market size is estimated to surpass USD 400 million by the end of 2033, growing at a CAGR of 6% during the forecast period, i.e., 2023-2033. In the year 2022, the industry size of autotransfusion devices was over USD 250 million. The growth of the market can primarily be ascribed to the number of patients in need of surgical care. As per the WHO, over 2 million surgical procedures were performed in 2018 across the globe. Moreover, instances of surgical burden are to expected rise by approximately 30% in the next few years.

The rising need for blood donation and increased volumes of donated blood, combined with the rising need for blood transfusion, is expected to boost the growth of the global autotransfusion devices market. As per the reported data, globally, every year about 118.5 million units of donated blood are collected. Additionally, in India, nearly 25-30 thousand people require liver transplants and about 50,000 person gets a heart attack. Furthermore, around 6,721 people are waiting for organ transplantation in the United Kingdom.

Autotransfusion is the procedure of transferring a patient's own blood into their body during cardiac or orthopedic surgery after component separation, and filtration. On the other hand, allogeneic blood transfusions can result in tumor progression, post-operative infections, severe lung injury, post-operative cardiovascular failures, and early death. For instance, multiple patient-based analysts predict that the pervasiveness of transfusion-associated circulatory overload (TACO) and transfusion-related acute lung injury (TRALI) in the United States is about 1.0% and 0.1%, respectively. As a result, shifting the priority forward into cell salvage can greatly decrease the need for allogeneic blood transfusion, decreasing the likelihood of detrimental ailments. As a result, the switch toward autologous blood transfusion is an eminent trend that is predicted to drive the market’s growth.

Autotransfusion Devices Market
Get more information on this report: Request Free Sample PDF

Autotransfusion Devices Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing Burden of Chronic Disease on the World- Deaths and impairments from chronic obstructive pulmonary illness are rising across most regions. Moreover, chronic disease potential consequences are also expanding. As a result, the treatment and surgery for a wide range of chronic diseases is anticipated to increase the demand for autotransfusion devices. According to the records of the National Library of Medicine, worldwide, every 3 in 5 deaths is caused by cardiovascular disease, cancer, chronic lung problems, and diabetes.
  •  The Rising Number of Surgical Procedures Operated Across the World- Cell salvage and blood transfusions are critical components of blood conservation during every surgical operation. In addition, the increased blood transfusion diagnostics are done in order to detect any infection in the blood before the transfusion. Furthermore, the greater focus on ignoring the hazards connected with allogeneic transfusions, along with an expanding number of bleeding-intensive surgeries, is expected to propel overall market expansion over the coming years. Globally nearly 11% of worldwide disease requires surgical treatment. Furthermore, there are nearly 310 million surgical procedures are carried out every year.
  • Increase in the Number of People with Kidney Problems- Chronic kidney disease is a progressive illness that impacts more than 10% of the global population. Chronic kidney disease is more common in older adults, women, racial minorities, and individuals with diabetes and high blood pressure. Nearly 850 million people all over the world have developed some sort of kidney disease.
  •  Surge in Population Percentage of Old-Adult- According to the WHO, by 2030, every 1 in 6 people is likely to be aged 60 years or above. Moreover, between 2015-2050, the worldwide older population is to get double, from nearly 12% to 22%.
  •  Rising Need for Blood Transfusion- According to the World Health Organization, the global share of blood transfusion in children is 54%, and nearly 76% of adults above 60 years of age.


  • Higher Prevalence of Minimally Invasive Surgery - Minimal invasion is highly adopted, and factors such as less pain, fast recovery, minimal blood loss, and higher comfort of patients are resulting higher number of people choosing it over traditional surgery. Therefore, it is likely to hamper the market’s growth.
  • Increased Use of Hemostatic Devices for Transfusions
  • Difficulty in Separating Contaminants from Blood

Autotransfusion Devices Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2022)

~USD 250 Million

Forecast Year Market Size (2033)

~USD 400 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Autotransfusion Devices Segmentation

Application (Orthopedic, Cardiovascular, Neurological, Gynecological, Obstetrics, Other Surgeries)

The autotransfusion devices market is segmented and analyzed for demand and supply by application into orthopedic, cardiovascular, neurological, gynecological, obstetrics, and other surgeries. Out of all, the cardiovascular surgery segment is anticipated to hold the largest market size by the end of 2033. Increased instances of cardiovascular issues are creating higher demands for transplantation, surgery, and autotransfusion, which is likely to drive the growth of the segment. According to the World Health Organization, nearly 17.9 million people are dying of cardiovascular disease every year, and cardiovascular is the primary reason for most of the deaths in the world.

Product Type (Autotransfusion Systems, Accessories)

The autotransfusion devices market is segmented and analyzed for demand and supply by product type into autotransfusion systems, and accessories. Out of all, autotransfusion systems are expected to hold the highest market size by the end of 2033. Owing to their reliability in blood transfusion, autotransfusion systems are becoming more popular in both developed and emerging nations, which is predicted to propel expansion in this segment over the coming years. Furthermore, adaptability, transfusion reporting mechanisms, technological developments for enhanced clinical outcomes, and communication are predicted to propel the expansion of the dual-mode autotransfusion systems segment in the market by 2033. In November 2022, LivaNova US introduced the XtraTM autotransfusion system, which serves as a full blood management system. It combines three decades of expertise and advancements in cell salvage methods.

Our in-depth analysis of the global market includes the following segments:

             By Application

  • Orthopedic Surgery
  • Cardiovascular Surgery
  • Neurological Surgery
  • Gynecological Surgery
  • Obstetrics
  • Other Surgeries

             By Product Type

  • Autotransfusion Systems
  • Accessories

             By End User

  • Hospitals
  •  Specialty Clinics
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Autotransfusion Devices Industry - Regional Synopsis

APAC Market Statistics

On the other hand, the Asia Pacific market is projected to expand at the fastest CAGR owing to the entry of new industry players, and the increasing acceptance of cell salvage technologies. Furthermore, the steadily expanding number of surgeries performed in China and India, along with the emerging health services, are expected to create significant growth possibilities for the region. According to the most recent statistical report, Chinese hospitals operated more than 81 million inpatient surgeries in 2021.

North American Market Forecast

The North America autotransfusion devices market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The growth of the market can be ascribed to the account of higher cases of chronic disease among the population propelling the market growth in the United States. According to the Centers for Disease Control and Prevention, every 6 in 10 adults are living with a chronic disease, and every 4 in 10 have more than 1 chronic problem. Furthermore, there has been a rise in organ transplantation and other surgeries in the region, that is further predicted to surge the market’s growth in the region. In the United States, at the current time, nearly 121,000 people are waiting for kidney transplantation. Also, the region's sales growth is expected to be driven by the rising usage of autologous blood transfusion in significant cardiovascular and orthopedic surgeries, in addition to the existence of established healthcare facilities. For instance, as per the American Association of Blood Banks guidelines, postoperative and intraoperative autotransfusion are conducted in surgeries in which 20% of overall surgical bleeding is anticipated.

Research Nester
Autotransfusion Devices Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Autotransfusion Devices Landscape

    • ProCell Surgical Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • BD (Becton, Dickinson and Company)
    • Fresenius SE & Co. KGaA
    • Medtronic
    • Beijing Jingjing Medical Equipment Co., Ltd.
    • Haematonics Corporation
    • LivaNova PLC
    • Zimmer Biomet
    • SARSTEDT AG & Co. KG
    • Gen World Medical Devices


In The News

  • ProCell Surgical Inc. announces its first patient blood management device, ProCell. Procell’s Sponge Blood Recovery is the extraction of blood during the surgical process in intraoperative transfusion.

  • Haemnotics Corporation join hands with Epic, a leading company for delivering electronic health record systems, to provide innovative medical solutions and better results for patients.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4459
  • Published Date: Feb 24, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rise in geriatric population, growing cases of chronic disease, higher blood donation & blood transfusion and rise in surgery are few factors likely to propel the market growth.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2033.

Rising adoption of minimally invasive surgery, increased usage of hemostatic devices for the transfusions and inefficient separating technique of contaminant from the blood are the few factors likely to hamper the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are ProCell Surgical Inc., BD (Becton, Dickinson and Company), Fresenius SE & Co. KGaA, Medtronic, Beijing Jingjing Medical Equipment Co., Ltd., Haematonics Corporation, LivaNova PLC, Zimmer Biomet, SARSTEDT AG & Co. KG, Gen World Medical Devices, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by application, product type, end user, and by region.

The cardiovascular surgery is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Autotransfusion Devices Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying